Soleno Therapeutics (SLNO) Shareholder's Equity Growth (1y) (2014 - 2026)
Soleno Therapeutics (SLNO) Shareholder's Equity Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Soleno Therapeutics |
2.76 Bn |
2.51 Bn |
93.41 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
113.47% |
| Dec 31, 2025 |
83.64% |
| Sep 30, 2025 |
86.93% |
| Jun 30, 2025 |
-14.47% |
| Mar 31, 2025 |
61.98% |
| Dec 31, 2024 |
55.62% |
| Sep 30, 2024 |
1,039.96% |
| Jun 30, 2024 |
2,159.43% |
| Mar 31, 2024 |
5,333.35% |
| Dec 31, 2023 |
1,422.10% |
| Sep 30, 2023 |
52.76% |
| Jun 30, 2023 |
-38.81% |
| Mar 31, 2023 |
-90.03% |
| Dec 31, 2022 |
-41.84% |
| Sep 30, 2022 |
-24.76% |
| Jun 30, 2022 |
-25.98% |
| Mar 31, 2022 |
-29.57% |
| Dec 31, 2021 |
-60.93% |
| Sep 30, 2021 |
-57.92% |
| Jun 30, 2021 |
-51.16% |
